Venue
Webinar

What is Qwoted?

Qwoted is a free expert network: we help reporters connect with experts & we help those same experts build relationships with top reporters.

Event Date Thu May 29 UTC (9 days ago)
In your timezone (EDT): Wed May 28 8:00pm - Wed May 28 8:00pm
Location Webinar
Region All
Details

Why attend?
• The biotech industry is in a transformative phase, with evolving therapeutic areas and innovative funding models reshaping its future. As mergers and acquisitions (M&A) continue to drive investment, identifying the optimal timing for exits becomes crucial in maximising asset value. Our panel will delve into the key catalysts, including the data that influences asset valuation and strategies for successful exits.

• Additionally, they will explore how the evolving ecosystem—comprising emerging therapeutic areas such as gene therapy and immunotherapy, research collaborators like CROs, and new funding models—affects drug development and investment decisions. By examining the interplay between these factors, the discussion will highlight strategies for creating value, reducing risk, and fostering continued innovation in the biotech space.

Learning objectives of this webinar:
• How to identify major market influences underpinning biotech asset valuation and optimal exit strategies.
• The impact of emerging therapeutic areas – such as gene therapy and immunotherapy – on long-term value creation
• How evolving funding models and strategic partnerships shape drug development and investment decisions
• Strategies for navigating M&A trends and reducing risk potential risks, all while maintaining a steady pace of innovation

Speakers

2025 Speakers

Dr. Will Maier
Senior Vice President & Head of Drug Development Solutions, ICON Biotech

Dr. Liz O’Brien
Therapeutic Expert Oncology, Drug Development Solutions, ICON

Georg Schragel
Director of Business Development, Genmab

Quentin Horgan
Associate Director of Drugs Intelligence, GlobalData

Sponsors & Partners

2025 Sponsor

• Icon Biotech